Concepts (345)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Living Donors | 32 | 2020 | 652 | 8.61 | Why? |
| Kidney Transplantation | 66 | 2021 | 5397 | 5.80 | Why? |
| Kidney Failure, Chronic | 31 | 2020 | 3222 | 4.00 | Why? |
| Tissue and Organ Procurement | 26 | 2020 | 1277 | 3.44 | Why? |
| Tissue Donors | 21 | 2020 | 1679 | 3.34 | Why? |
| Waiting Lists | 20 | 2020 | 1388 | 2.67 | Why? |
| Nephrectomy | 8 | 2019 | 406 | 2.47 | Why? |
| Transplant Recipients | 33 | 2021 | 4982 | 2.38 | Why? |
| Delayed Graft Function | 4 | 2020 | 52 | 2.36 | Why? |
| Liver Transplantation | 16 | 2021 | 2864 | 2.34 | Why? |
| Donor Selection | 13 | 2019 | 804 | 2.15 | Why? |
| Graft Rejection | 17 | 2021 | 1766 | 2.14 | Why? |
| Graft Survival | 24 | 2020 | 587 | 2.07 | Why? |
| End Stage Liver Disease | 6 | 2018 | 418 | 1.92 | Why? |
| Organ Transplantation | 20 | 2021 | 2616 | 1.77 | Why? |
| Tissue and Organ Harvesting | 2 | 2017 | 146 | 1.23 | Why? |
| Frailty | 8 | 2019 | 1432 | 1.10 | Why? |
| Cold Ischemia | 2 | 2020 | 37 | 0.94 | Why? |
| Blood Group Incompatibility | 2 | 2017 | 44 | 0.87 | Why? |
| HLA Antigens | 5 | 2020 | 830 | 0.85 | Why? |
| Registries | 27 | 2020 | 12327 | 0.82 | Why? |
| Postoperative Complications | 12 | 2020 | 5861 | 0.82 | Why? |
| Healthcare Disparities | 7 | 2018 | 3893 | 0.74 | Why? |
| Tendon Injuries | 1 | 2018 | 27 | 0.72 | Why? |
| Achilles Tendon | 1 | 2018 | 26 | 0.72 | Why? |
| Organ Preservation | 1 | 2018 | 49 | 0.72 | Why? |
| Follow-Up Studies | 25 | 2021 | 17020 | 0.70 | Why? |
| Electronic Mail | 1 | 2018 | 102 | 0.67 | Why? |
| Perfusion | 1 | 2018 | 254 | 0.67 | Why? |
| Asian Americans | 2 | 2018 | 387 | 0.66 | Why? |
| Resource Allocation | 5 | 2020 | 1771 | 0.64 | Why? |
| Brain Death | 1 | 2018 | 146 | 0.63 | Why? |
| Legislation, Medical | 1 | 2017 | 66 | 0.62 | Why? |
| Allografts | 5 | 2020 | 761 | 0.61 | Why? |
| Financial Support | 1 | 2017 | 170 | 0.59 | Why? |
| United States | 42 | 2021 | 46150 | 0.59 | Why? |
| Family Relations | 1 | 2018 | 288 | 0.58 | Why? |
| Liver Failure | 1 | 2018 | 266 | 0.55 | Why? |
| Conflict of Interest | 1 | 2017 | 175 | 0.55 | Why? |
| Informed Consent | 2 | 2018 | 890 | 0.53 | Why? |
| Postoperative Period | 1 | 2015 | 651 | 0.50 | Why? |
| Adult | 68 | 2022 | 244371 | 0.48 | Why? |
| Glomerular Filtration Rate | 5 | 2019 | 1262 | 0.48 | Why? |
| Disclosure | 1 | 2017 | 423 | 0.47 | Why? |
| Middle Aged | 70 | 2021 | 270681 | 0.47 | Why? |
| Male | 83 | 2021 | 367725 | 0.46 | Why? |
| Kidney Function Tests | 4 | 2018 | 520 | 0.46 | Why? |
| Female | 83 | 2021 | 380317 | 0.46 | Why? |
| Decision Support Techniques | 2 | 2018 | 903 | 0.45 | Why? |
| Social Networking | 1 | 2018 | 737 | 0.45 | Why? |
| Patient Readmission | 2 | 2017 | 1543 | 0.43 | Why? |
| Immunocompromised Host | 4 | 2021 | 5150 | 0.43 | Why? |
| African Americans | 5 | 2018 | 3363 | 0.43 | Why? |
| Histocompatibility Testing | 3 | 2020 | 219 | 0.40 | Why? |
| Renal Insufficiency | 4 | 2021 | 810 | 0.40 | Why? |
| Musculoskeletal Diseases | 3 | 2021 | 646 | 0.39 | Why? |
| Self Care | 1 | 2018 | 918 | 0.39 | Why? |
| Risk Assessment | 18 | 2021 | 25439 | 0.38 | Why? |
| Immunogenicity, Vaccine | 5 | 2021 | 4624 | 0.38 | Why? |
| Humans | 120 | 2022 | 930598 | 0.37 | Why? |
| Drug Industry | 1 | 2017 | 689 | 0.37 | Why? |
| Residence Characteristics | 1 | 2019 | 1927 | 0.37 | Why? |
| Quality of Life | 4 | 2018 | 9820 | 0.36 | Why? |
| Poverty | 1 | 2019 | 2302 | 0.34 | Why? |
| HIV Infections | 8 | 2021 | 11620 | 0.33 | Why? |
| Risk Factors | 30 | 2021 | 71621 | 0.33 | Why? |
| Surgery, Plastic | 1 | 2017 | 761 | 0.33 | Why? |
| Incidence | 14 | 2021 | 25622 | 0.31 | Why? |
| Isoantibodies | 2 | 2017 | 134 | 0.31 | Why? |
| Prognosis | 16 | 2020 | 32490 | 0.30 | Why? |
| Emotions | 1 | 2018 | 2418 | 0.30 | Why? |
| Immunosuppressive Agents | 9 | 2021 | 6331 | 0.30 | Why? |
| Histocompatibility | 3 | 2019 | 53 | 0.28 | Why? |
| Health Plan Implementation | 2 | 2020 | 571 | 0.28 | Why? |
| Time Factors | 14 | 2019 | 31397 | 0.27 | Why? |
| Antibody Formation | 6 | 2021 | 4038 | 0.26 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.26 | Why? |
| Practice Patterns, Physicians' | 5 | 2020 | 4927 | 0.26 | Why? |
| Prospective Studies | 17 | 2021 | 43301 | 0.26 | Why? |
| Surgeons | 2 | 2018 | 2233 | 0.25 | Why? |
| Young Adult | 25 | 2021 | 93724 | 0.25 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.25 | Why? |
| Colectomy | 2 | 2018 | 327 | 0.25 | Why? |
| Hypertension | 3 | 2019 | 8895 | 0.25 | Why? |
| Body Mass Index | 5 | 2019 | 4306 | 0.25 | Why? |
| Hepatitis C | 3 | 2018 | 1514 | 0.25 | Why? |
| Aged | 36 | 2021 | 215776 | 0.24 | Why? |
| Obesity | 3 | 2019 | 7388 | 0.24 | Why? |
| Antibodies, Viral | 14 | 2021 | 51949 | 0.23 | Why? |
| Survival Rate | 6 | 2020 | 9206 | 0.23 | Why? |
| Cognition | 4 | 2019 | 1394 | 0.23 | Why? |
| Health Status Disparities | 1 | 2019 | 4072 | 0.22 | Why? |
| Sex Factors | 5 | 2019 | 11014 | 0.22 | Why? |
| Appendectomy | 2 | 2018 | 585 | 0.22 | Why? |
| Adolescent | 23 | 2021 | 86841 | 0.22 | Why? |
| Rheumatic Diseases | 3 | 2021 | 2675 | 0.22 | Why? |
| Proportional Hazards Models | 7 | 2019 | 6543 | 0.21 | Why? |
| Treatment Outcome | 15 | 2020 | 51732 | 0.21 | Why? |
| Maryland | 3 | 2019 | 436 | 0.21 | Why? |
| Maintenance Chemotherapy | 1 | 2020 | 133 | 0.21 | Why? |
| Patient Selection | 6 | 2018 | 4560 | 0.20 | Why? |
| Longitudinal Studies | 8 | 2019 | 9893 | 0.20 | Why? |
| Abatacept | 1 | 2021 | 192 | 0.20 | Why? |
| Heart Transplantation | 2 | 2021 | 1293 | 0.20 | Why? |
| Communication | 1 | 2018 | 5206 | 0.20 | Why? |
| Mobility Limitation | 1 | 2020 | 153 | 0.19 | Why? |
| Leukocyte Reduction Procedures | 1 | 2018 | 19 | 0.19 | Why? |
| Lymphocyte Depletion | 1 | 2021 | 293 | 0.19 | Why? |
| Health Behavior | 1 | 2017 | 4449 | 0.19 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.18 | Why? |
| Preoperative Period | 2 | 2019 | 271 | 0.18 | Why? |
| Rupture | 1 | 2018 | 40 | 0.18 | Why? |
| Hospital Costs | 2 | 2018 | 274 | 0.18 | Why? |
| Hepatitis C Antibodies | 1 | 2018 | 120 | 0.18 | Why? |
| Analgesics, Opioid | 2 | 2019 | 1070 | 0.18 | Why? |
| Length of Stay | 5 | 2018 | 11042 | 0.18 | Why? |
| Transplantation | 1 | 2018 | 72 | 0.18 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.17 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 229 | 0.17 | Why? |
| Medical Record Linkage | 1 | 2017 | 58 | 0.17 | Why? |
| Gift Giving | 1 | 2017 | 33 | 0.17 | Why? |
| Multivariate Analysis | 4 | 2018 | 5440 | 0.16 | Why? |
| Infant, Newborn | 7 | 2020 | 23105 | 0.16 | Why? |
| Apolipoprotein L1 | 1 | 2018 | 161 | 0.16 | Why? |
| Depression | 2 | 2018 | 14116 | 0.16 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.16 | Why? |
| Vision Disorders | 1 | 2020 | 260 | 0.16 | Why? |
| Hearing Loss | 1 | 2020 | 225 | 0.16 | Why? |
| Vaccines, Synthetic | 4 | 2021 | 3231 | 0.16 | Why? |
| Kidney | 4 | 2019 | 3648 | 0.16 | Why? |
| Pulmonary Aspergillosis | 1 | 2022 | 408 | 0.16 | Why? |
| Cholecystectomy | 1 | 2018 | 198 | 0.15 | Why? |
| Aircraft | 1 | 2020 | 498 | 0.15 | Why? |
| Kidney Diseases | 2 | 2017 | 1434 | 0.15 | Why? |
| Predictive Value of Tests | 4 | 2018 | 9537 | 0.15 | Why? |
| Health Services Accessibility | 4 | 2020 | 10697 | 0.15 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.15 | Why? |
| Infant | 7 | 2020 | 30274 | 0.15 | Why? |
| Databases, Factual | 4 | 2018 | 6248 | 0.14 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.14 | Why? |
| Surveys and Questionnaires | 4 | 2020 | 43792 | 0.14 | Why? |
| Independent Living | 2 | 2018 | 842 | 0.14 | Why? |
| Aged, 80 and over | 13 | 2021 | 88759 | 0.14 | Why? |
| Renal Insufficiency, Chronic | 3 | 2018 | 2654 | 0.14 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2022 | 634 | 0.14 | Why? |
| HIV | 2 | 2018 | 1116 | 0.14 | Why? |
| Antibodies | 2 | 2018 | 846 | 0.14 | Why? |
| Child, Preschool | 7 | 2020 | 36283 | 0.13 | Why? |
| Health Care Sector | 1 | 2017 | 191 | 0.13 | Why? |
| Scleroderma, Systemic | 1 | 2020 | 583 | 0.13 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.13 | Why? |
| Age Factors | 6 | 2019 | 21039 | 0.13 | Why? |
| Prescription Drugs | 1 | 2017 | 243 | 0.13 | Why? |
| Lower Extremity | 1 | 2018 | 593 | 0.13 | Why? |
| Delphi Technique | 1 | 2018 | 1257 | 0.12 | Why? |
| Fractures, Bone | 1 | 2019 | 487 | 0.12 | Why? |
| Liver | 2 | 2018 | 4007 | 0.12 | Why? |
| Hysterectomy | 1 | 2014 | 171 | 0.12 | Why? |
| Cadaver | 1 | 2017 | 626 | 0.12 | Why? |
| Anxiety | 1 | 2018 | 17311 | 0.12 | Why? |
| Warfarin | 1 | 2017 | 402 | 0.12 | Why? |
| Antidepressive Agents | 1 | 2017 | 509 | 0.12 | Why? |
| Immunity, Humoral | 3 | 2021 | 4849 | 0.12 | Why? |
| Program Evaluation | 1 | 2020 | 1929 | 0.11 | Why? |
| Vaccination | 6 | 2021 | 19050 | 0.11 | Why? |
| Child | 10 | 2020 | 70012 | 0.11 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.11 | Why? |
| Linear Models | 3 | 2018 | 1914 | 0.11 | Why? |
| Geography | 1 | 2017 | 1801 | 0.11 | Why? |
| Mass Vaccination | 1 | 2021 | 1101 | 0.11 | Why? |
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 8811 | 0.11 | Why? |
| Renal Dialysis | 3 | 2018 | 4358 | 0.11 | Why? |
| Nephrology | 1 | 2017 | 546 | 0.11 | Why? |
| Pneumonectomy | 1 | 2014 | 278 | 0.11 | Why? |
| Drug Prescriptions | 1 | 2019 | 1062 | 0.11 | Why? |
| Interleukin-1 | 1 | 2014 | 438 | 0.11 | Why? |
| Patient Participation | 1 | 2018 | 829 | 0.10 | Why? |
| Health Services for the Aged | 1 | 2018 | 602 | 0.10 | Why? |
| Retrospective Studies | 17 | 2022 | 105322 | 0.10 | Why? |
| Cognition Disorders | 1 | 2015 | 574 | 0.10 | Why? |
| Patient Acceptance of Health Care | 2 | 2019 | 5002 | 0.10 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.10 | Why? |
| Disabled Persons | 1 | 2020 | 1152 | 0.10 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.09 | Why? |
| Pain | 1 | 2017 | 1084 | 0.09 | Why? |
| Cohort Studies | 5 | 2018 | 36005 | 0.09 | Why? |
| Physician's Role | 1 | 2018 | 853 | 0.09 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2014 | 663 | 0.09 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.09 | Why? |
| Telemedicine | 4 | 2020 | 25032 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| ABO Blood-Group System | 1 | 2017 | 995 | 0.09 | Why? |
| Frail Elderly | 1 | 2018 | 1427 | 0.09 | Why? |
| Cytomegalovirus Infections | 1 | 2014 | 667 | 0.09 | Why? |
| Delirium | 1 | 2018 | 1061 | 0.09 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.09 | Why? |
| Cognitive Dysfunction | 1 | 2019 | 1389 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2017 | 973 | 0.08 | Why? |
| Motivation | 1 | 2018 | 1640 | 0.08 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Self Report | 1 | 2019 | 3802 | 0.08 | Why? |
| Opioid-Related Disorders | 1 | 2019 | 1185 | 0.08 | Why? |
| Health Surveys | 1 | 2018 | 2841 | 0.08 | Why? |
| Perioperative Care | 1 | 2017 | 1329 | 0.08 | Why? |
| Depressive Disorder | 1 | 2017 | 1236 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Laparoscopy | 1 | 2018 | 1532 | 0.08 | Why? |
| Case-Control Studies | 4 | 2018 | 17671 | 0.08 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.08 | Why? |
| Transplantation Immunology | 2 | 2017 | 99 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Patient Safety | 1 | 2021 | 4885 | 0.08 | Why? |
| Health Policy | 3 | 2020 | 6242 | 0.07 | Why? |
| Prejudice | 1 | 2009 | 245 | 0.07 | Why? |
| Patient Discharge | 2 | 2018 | 5696 | 0.07 | Why? |
| Death | 2 | 2019 | 334 | 0.07 | Why? |
| Survival Analysis | 4 | 2019 | 7592 | 0.07 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.07 | Why? |
| Liver Diseases | 1 | 2019 | 2698 | 0.07 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.06 | Why? |
| Health Care Rationing | 1 | 2018 | 2558 | 0.06 | Why? |
| RNA, Messenger | 3 | 2021 | 5131 | 0.06 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.06 | Why? |
| Medicare | 2 | 2020 | 1048 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2017 | 2320 | 0.06 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.06 | Why? |
| Pediatrics | 1 | 2018 | 2969 | 0.06 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2020 | 9335 | 0.06 | Why? |
| Health Status | 1 | 2015 | 3259 | 0.06 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.05 | Why? |
| Clinical Decision-Making | 3 | 2020 | 3755 | 0.05 | Why? |
| Sex Characteristics | 1 | 2009 | 1120 | 0.05 | Why? |
| Health Insurance Portability and Accountability Act | 1 | 2020 | 69 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.05 | Why? |
| Health Care Surveys | 2 | 2020 | 2942 | 0.05 | Why? |
| Licensure | 1 | 2020 | 144 | 0.05 | Why? |
| Immunoenzyme Techniques | 1 | 2021 | 448 | 0.05 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.05 | Why? |
| Complement Inactivator Proteins | 1 | 2017 | 14 | 0.05 | Why? |
| Motor Activity | 1 | 2020 | 217 | 0.05 | Why? |
| Chemokine CXCL11 | 1 | 2017 | 48 | 0.04 | Why? |
| Reimbursement Mechanisms | 1 | 2020 | 243 | 0.04 | Why? |
| Symptom Flare Up | 1 | 2021 | 432 | 0.04 | Why? |
| Chemokine CCL4 | 1 | 2017 | 71 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Poisson Distribution | 1 | 2018 | 348 | 0.04 | Why? |
| Hospital Mortality | 2 | 2018 | 22087 | 0.04 | Why? |
| Platelet Transfusion | 1 | 2018 | 209 | 0.04 | Why? |
| Transplants | 1 | 2018 | 136 | 0.04 | Why? |
| Trail Making Test | 1 | 2015 | 5 | 0.04 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.04 | Why? |
| State Government | 1 | 2020 | 416 | 0.04 | Why? |
| Eligibility Determination | 1 | 2018 | 255 | 0.04 | Why? |
| Prevalence | 4 | 2019 | 25773 | 0.04 | Why? |
| Walking | 1 | 2020 | 442 | 0.04 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.04 | Why? |
| Antiviral Agents | 2 | 2018 | 41703 | 0.04 | Why? |
| Confidentiality | 1 | 2020 | 581 | 0.04 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.04 | Why? |
| Rehabilitation Centers | 1 | 2018 | 252 | 0.04 | Why? |
| Information Storage and Retrieval | 1 | 2020 | 644 | 0.04 | Why? |
| Insurance, Health | 1 | 2020 | 634 | 0.04 | Why? |
| Erythrocyte Transfusion | 1 | 2018 | 386 | 0.03 | Why? |
| Hospitals | 1 | 2014 | 11793 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Focus Groups | 1 | 2018 | 811 | 0.03 | Why? |
| Complement System Proteins | 1 | 2017 | 380 | 0.03 | Why? |
| Receptors, IgG | 1 | 2017 | 578 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2014 | 325 | 0.03 | Why? |
| Hospitals, Special | 1 | 2018 | 523 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2019 | 15909 | 0.03 | Why? |
| Attention | 1 | 2015 | 335 | 0.03 | Why? |
| Health Status Indicators | 1 | 2015 | 341 | 0.03 | Why? |
| Travel | 1 | 2010 | 7220 | 0.03 | Why? |
| Reference Values | 1 | 2014 | 795 | 0.03 | Why? |
| Immune System | 1 | 2021 | 1479 | 0.03 | Why? |
| Ontario | 1 | 2018 | 1966 | 0.03 | Why? |
| Analysis of Variance | 1 | 2014 | 950 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2014 | 1008 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Plasma Exchange | 1 | 2017 | 763 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Interviews as Topic | 1 | 2019 | 1952 | 0.02 | Why? |
| Hospitalization | 2 | 2018 | 54280 | 0.02 | Why? |
| Skilled Nursing Facilities | 1 | 2018 | 1098 | 0.02 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.02 | Why? |
| Health Personnel | 1 | 2019 | 29646 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.02 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.02 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.02 | Why? |
| Viremia | 1 | 2014 | 1020 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Dendritic Cells | 1 | 2014 | 1330 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.02 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.02 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.02 | Why? |
| Canada | 1 | 2018 | 6018 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Australia | 1 | 2018 | 6306 | 0.02 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.01 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.01 | Why? |
| Lymphocyte Count | 1 | 2014 | 4758 | 0.01 | Why? |
| Social Class | 1 | 2010 | 1360 | 0.01 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2014 | 6670 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2022 | 22116 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |